Bionik Laboratories Corp.
OTC: BNKL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Richard Paul Russo Jr.
- Employees
- 12
- Headquarters
- Watertown, United States
- IPO year
- 2015
- Market cap
- $1.2K
- Website
- https://www.bioniklabs.com
Loading BNKL…
Loading profile data…Frequently asked questions about BNKL
What does Bionik Laboratories Corp. (BNKL) do?
Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InM...
Where does BNKL trade?
Bionik Laboratories Corp. (BNKL) trades on the Other OTC.
What sector is BNKL in?
Bionik Laboratories Corp. (BNKL) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Bionik Laboratories Corp.?
Richard Paul Russo Jr. is the chief executive officer of Bionik Laboratories Corp. (BNKL).
Where is Bionik Laboratories Corp. headquartered?
Bionik Laboratories Corp. is headquartered in United States.
Does BNKL pay a dividend?
Bionik Laboratories Corp. (BNKL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BNKL go public?
Bionik Laboratories Corp. (BNKL) completed its initial public offering in 2015.